Intract Pharma Limited

  • Active
  • Small
  • 10 years
  • 6 employees
  • £1,385,825 (cur assets)
  • 1m-15m
  • Irregular importer
  • Virtual address
  • 4 directors
  • 1 owner
  • Cambridge
  • Rating 5.0 (1)

Field of Operation

Research and experimental development on biotechnology
72110 6232 companies

Website

Social media

Summary

Intract Pharma Ltd from Cambridge UK is a small, active company founded nine years ago. With seven employees and £274,153 in assets, it operates from a virtual address, managed by four directors and a single owner. The company boasts a perfect 5.0 Google rating based on one review. It’s an irregular importer of pharmaceutical products, with just one month of imports recorded as of January 2022.

The company’s website highlights its focus on transforming patient care by replacing injections with safer, more effective oral therapies. It’s developing innovative drug delivery technologies, including “Soteria” for oral biopharmaceutical delivery and “Phloral” for targeted colon delivery. The site showcases research and development efforts, featuring news updates on partnerships and preclinical results. It's clear the company is dedicated to research and experimental development in the biotechnology industries.

Financially, Intract Pharma Ltd presents a mixed picture. Current assets have fallen by a significant 58% to £270,000, and net assets have plummeted 55% to £300,000. Cash reserves have also taken a hit, dropping 57% to £240,000. Trade debtors have shrunk dramatically, down 97%, which is good news, but bank borrowings have increased. Director remuneration has decreased by 14%, which could be a result of the company’s current financial state. The company meets two of the three criteria to be considered small—turnover under £10.2m, assets under £5.1m, and fewer than 50 employees—and, as a small company, it is exempt from an audit.

Overall, Intract Pharma Ltd seems to be facing financial challenges, although it’s difficult to say if this is a typical startup phase or a longer-term concern. The company’s focus on cutting-edge drug delivery technologies suggests a strong potential for future growth, but it will need to navigate these financial pressures to realize its ambitions.

Registered in England/Wales under the registration number 09610219, with a registered address at CB22 5EG, England, Cambridge, 5 High Green, Great Shelford.

WARNING: The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.

Owners & PSC

  • 3 years
  • psc

Managers

  • 3 years
Ceo
  • 10 years
Managing director
  • 10 years
  • 5
Managing director
  • 10 years
  • 1
University professor

Last reports

Download the last financial report
Download the last confirmation report
* may contain a full shareholder list

Last news

  1. Total exemption full accounts made up to 2025-05-31
  2. Confirmation statement made on 2025-05-27 with no updates
  3. Total exemption full accounts made up to 2024-05-31

Importer profile by HS codes

Click on the map to see detailed UK statistics on HS code, including companies list.

Import HS codes in detail

Last imported products

Click on items to see detailed UK statistics on HS code, including companies list.

* Warning: Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.

FAQ about Intract Pharma Limited

Looking for leads in the UK?

Book a demo—see how CorpSignals can help you find UK leads.

Similar companies